Application of SUZ12 mediating undifferentiated thyroid cancer cell dedifferentiation
A SUZ12, thyroid cancer technology, applied in the field of basic medicine, can solve the problem of unclear influence of differentiation ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0027] The present invention will be described in detail below in conjunction with the accompanying drawings and specific implementation steps. The implementation steps are only used to explain the present invention, and are not limited to the present invention. The methods used in the following implementation steps are conventional operations unless otherwise specified, and the materials and reagents can be purchased from the market unless otherwise specified.
[0028] 1 Materials and methods
[0029] 1.1 Reagents and cells
[0030] RPMI-1640 cell culture medium and neonatal bovine bovine serum were purchased from Gibico, USA; ASPM knockout plasmids, SUZ12 overexpression and knockout plasmids were purchased from Jiangsu Aibimeng Biotechnology Co., Ltd.; anti-ASPM, anti-TSHR, Anti-NIS and anti-SUZ12 antibodies were purchased from CST Company in the United States, anti-GAPDH and secondary antibodies were purchased from Lianke Biotechnology Co., Ltd.; Lipofectamine3000 was purc...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap